Citadel Advisors’s Bioceres Crop Solutions BIOX Stock Holding History

Citadel Advisors’s Portfolio BIOX Stock Details BIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-143,748	Closed	-$230K	–	12692
2025 Q3	$203K	Buy	143,748 +28,856	+25%	+$88K	﹤0.01%	11238
2025 Q2	$514K	Buy	114,892 +59,233	+106%	+$267K	﹤0.01%	8567
2025 Q1	$254K	Sell	55,659 -58,858	-51%	-$324K	﹤0.01%	9954
2024 Q4	$696K	Buy	114,517 +42,738	+60%	+$292K	﹤0.01%	7842
2024 Q3	$565K	Buy	71,779 +66,047	+1,152%	+$666K	﹤0.01%	8002
2024 Q2	$64.3K	Sell	5,732 -23,843	-81%	-$279K	﹤0.01%	11481
2024 Q1	$374K	Buy	+29,575	New	+$390K	﹤0.01%	8992
2023 Q3	–	Sell	-5,401	Closed	-$64.7K	–	14292
2023 Q2	$72.2K	Buy	5,401 +4,934	+1,057%	+$57.9K	﹤0.01%	11356
2023 Q1	$5.42K	Sell	467 -80,463	-99%	-$946K	﹤0.01%	13873
2022 Q4	$974K	Buy	+80,930	New	+$1.05M	﹤0.01%	6865
2021 Q2	–	Sell	-17,600	Closed	-$248K	–	13669
2021 Q1	$179K	Buy	+17,600	New	+$148K	﹤0.01%	11834

Other funds holding BIOX

Solel Partners Boston, Massachusetts $468M AUM 2.45% 1-Year Est. Return

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Citadel Advisors's BIOX Position: Q4 2025 in Review

Citadel Advisors sold out of Bioceres Crop Solutions (BIOX) in Q4 2025, closing a stake of 143,748 shares — an estimated $230K sold.

Citadel Advisors first reported a position in BIOX in Q1 2021 and held it in 11 quarters. The position peaked at $974K in Q4 2022. 37 funds tracked by Wall St. Rank hold BIOX as of Q4 2025.

Citadel Advisors reported no remaining Bioceres Crop Solutions position as of Q4 2025 after selling out during the quarter.
Citadel Advisors sold 143,748 Bioceres Crop Solutions shares in Q4 2025, an estimated $230K.
Citadel Advisors first reported a position in Bioceres Crop Solutions in Q1 2021 and held it in 11 quarters.
Citadel Advisors's Bioceres Crop Solutions position peaked at $974K in Q4 2022.
37 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.